Dr Heather Valerio

Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, vol. 14, http://dx.doi.org/10.3390/v14071555

Hosseini-Hooshyar S; Alavi M; Martinello M; Valerio H; Tillakeratne S; Matthews GV; Dore GJ, 2022, 'Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study', Journal of Viral Hepatitis, vol. 29, pp. 271 - 279, http://dx.doi.org/10.1111/jvh.13658

Marshall AD; Conway A; Cunningham EB; Valerio H; Silk D; Alavi M; Wade A; Lam T; Zohrab K; Dunlop A; Connelly C; Christmass M; Cock V; Burns C; Henderson C; Wiseman V; Dore GJ; Grebely J, 2022, 'Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment', Drug and Alcohol Dependence, vol. 235, pp. 109438, http://dx.doi.org/10.1016/j.drugalcdep.2022.109438

Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2022, 'Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales', JHEP Reports, vol. 4, pp. 100552 - 100552, http://dx.doi.org/10.1016/j.jhepr.2022.100552

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J; ETHOS Engage Study Group , 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.', Int J Drug Policy, vol. 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, vol. 237, pp. 109543, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543

Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ, 2022, 'Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia', Viruses, vol. 14, http://dx.doi.org/10.3390/v14071496

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, vol. 96, pp. 103421, http://dx.doi.org/10.1016/j.drugpo.2021.103421

Grebely J; Tran L; Degenhardt L; Dowell-Day A; Santo T; Larney S; Hickman M; Vickerman P; French C; Butler K; Gibbs D; Valerio H; Read P; Dore GJ; Hajarizadeh B, 2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, vol. 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612

Kwon JA; Dore GJ; Hajarizadeh B; Alavi M; Valerio H; Grebely J; Guy R; Gray RT, 2021, 'Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications', PLoS ONE, vol. 16, pp. e0257369, http://dx.doi.org/10.1371/journal.pone.0257369

Valerio H; Alavi M; Law M; McManus H; Tillakeratne S; Bajis S; Martinello M; Matthews GV; Amin J; Janjua NZ; Krajden M; George J; Degenhardt L; Grebely J; Dore GJ, 2021, 'Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study', Clinical Infectious Diseases, vol. 73, pp. 2037 - 2044, http://dx.doi.org/10.1093/cid/ciab526

Valerio H; Alavi M; Law M; Tillakeratne S; Amin J; Janjua NZ; Krajden M; George J; Matthews GV; Hajarizadeh B; Degenhardt L; Grebely J; Dore GJ, 2021, 'High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia', Journal of Hepatology, vol. 74, pp. 293 - 302, http://dx.doi.org/10.1016/j.jhep.2020.08.038

Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore GJ; Grebely J, 2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, vol. 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571

Dore GJ; Valerio H; Grebely J, 2020, 'Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C', Liver International, vol. 40, pp. 2353 - 2355, http://dx.doi.org/10.1111/liv.14661

Grebely J; Catlett B; Jayasinghe I; Valerio H; Hajarizadeh B; Verich A; Cunningham P; Martinello M; Tillakeratne S; Silk D; Dore GJ; Applegate TL, 2020, 'Time to Detection of Hepatitis C Virus Infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis', Journal of Infectious Diseases, vol. 221, pp. 2043 - 2049, http://dx.doi.org/10.1093/infdis/jiaa037

Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Law M; Janjua NZ; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore GJ; Grebely J, 2020, 'Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis', Journal of Hepatology, vol. 72, pp. 643 - 657, http://dx.doi.org/10.1016/j.jhep.2019.11.012

Hutchinson SJ; Valerio H; McDonald SA; Yeung A; Pollock K; Smith S; Barclay S; Dillon JF; Fox R; Bramley P; Fraser A; Kennedy N; Gunson RN; Templeton K; Innes H; McLeod A; Weir A; Hayes PC; Goldberg D, 2020, 'Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: A national record-linkage study', Gut, vol. 69, pp. 2223 - 2231, http://dx.doi.org/10.1136/gutjnl-2019-320007

Valerio H; Alavi M; Matthews G; Law M; McManus H; Amin J; Janjua N; Krajden M; Tillakeratne S; Gleeson V; George J; Degenhardt L; Grebely J; Dore G, 2020, 'Opportunities to enhance linkage to hepatitis C care among people hospitalised for injection drug use-related complications: a population-based study', JOURNAL OF HEPATOLOGY, vol. 73, pp. S807 - S808, http://dx.doi.org/10.1016/s0168-8278(20)32060-2

Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ, 2019, 'Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia', Journal of Hepatology, vol. 71, pp. 281 - 288, http://dx.doi.org/10.1016/j.jhep.2019.04.014

Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Reid H; Law M; Janjua N; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore G; Grebely J, 2019, 'SAT-233-Hepatitis C virus reinfection following antiviral treatment among people who inject drugs: A systematic review, meta-analysis, and meta-regression', Journal of Hepatology, vol. 70, pp. e733 - e733, http://dx.doi.org/10.1016/s0618-8278(19)31466-5

Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio H; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ, 2018, 'Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study', Journal of Viral Hepatitis, vol. 25, pp. 473 - 481, http://dx.doi.org/10.1111/jvh.12837

Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio HM; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ, 2018, 'The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study', Journal of Hepatology, vol. 68, pp. 393 - 401, http://dx.doi.org/10.1016/j.jhep.2017.10.019

Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L, 2018, 'Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality – results from two surveys (2016)', HIV Medicine, vol. 19, pp. 11 - 15, http://dx.doi.org/10.1111/hiv.12599

Hutchinson S; Valerio H; Dillon J; Fox R; Innes H; Weir A; Barclay S; Mcdonald S; Kennedy N; Fraser A; Stanley A; Bramley P; Hayes P; Goldberg D, 2018, 'Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis', Journal of Hepatology, vol. 68, pp. S67 - S67, http://dx.doi.org/10.1016/s0168-8278(18)30355-6

Innes H; Barclay ST; Hayes PC; Fraser A; Dillon JF; Stanley A; Bathgate A; McDonald SA; Goldberg D; Valerio H; Fox R; Kennedy N; Bramley P; Hutchinson SJ, 2018, 'The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen', Journal of Hepatology, vol. 68, pp. 646 - 654, http://dx.doi.org/10.1016/j.jhep.2017.10.033

Innes H; McAuley A; Alavi M; Valerio H; Goldberg D; Hutchinson SJ, 2018, 'The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort-study', Hepatology, vol. 67, pp. 97 - 107, http://dx.doi.org/10.1002/hep.29419

McDonald SA; Innes HA; Aspinall EJ; Hayes PC; Alavi M; Valerio H; Goldberg DJ; Hutchinson SJ, 2018, 'Inpatient hospital burden of hepatitis C-diagnosed patients with decompensated cirrhosis', Liver International, vol. 38, pp. 1402 - 1410, http://dx.doi.org/10.1111/liv.13681

Valerio H; McAuley A; Innes H; Palmateer N; Goldberg DJ; Munro A; Taylor A; Hutchinson SJ, 2018, 'Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era', International Journal of Drug Policy, vol. 52, pp. 115 - 122, http://dx.doi.org/10.1016/j.drugpo.2017.12.014

Wang H; Swann R; Thomas E; Innes HA; Valerio H; Hayes PC; Allen S; Barclay ST; Wilks D; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley AJ; Gunson R; Mclntyre PG; Hunt A; Hutchinson SJ; Mills PR; Dillon JF, 2018, 'Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis', Journal of Viral Hepatitis, vol. 25, pp. 930 - 938, http://dx.doi.org/10.1111/jvh.12897

Innes H; Barclay ST; Hayes PC; Fraser A; Dillon JF; Stanley A; Bathgate A; McDonald S; Goldberg D; Valerio H; Fox R; Kennedy N; Bramley P; Hutchinson SJ, 2017, 'Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort', Journal of Hepatology, vol. 66, pp. S22 - S23, http://dx.doi.org/10.1016/s0168-8278(17)30306-9

Innes H; McDonald S; Hayes P; Dillon JF; Allen S; Goldberg D; Mills PR; Barclay ST; Wilks D; Valerio H; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley A; Bramley P; Hutchinson SJ, 2017, 'Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population', Journal of Hepatology, vol. 66, pp. 19 - 27, http://dx.doi.org/10.1016/j.jhep.2016.08.004

McDonald SA; Innes HA; Aspinall E; Hayes PC; Alavi M; Valerio H; Goldberg DJ; Hutchinson SJ, 2017, 'Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era', Journal of Viral Hepatitis, vol. 24, pp. 295 - 303, http://dx.doi.org/10.1111/jvh.12646

Aspinall EJ; Mitchell W; Schofield J; Cairns A; Lamond S; Bramley P; Peters SE; Valerio H; Tomnay J; Goldberg DJ; Mills PR; Barclay ST; Fraser A; Dillon JF; Martin NK; Hickman M; Hutchinson SJ, 2016, 'A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy', Journal of Viral Hepatitis, vol. 23, pp. 1009 - 1016, http://dx.doi.org/10.1111/jvh.12580

Bulteel N; Partha Sarathy P; Forrest E; Stanley AJ; Innes H; Mills PR; Valerio H; Gunson RN; Aitken C; Morris J; Fox R; Barclay ST, 2016, 'Factors associated with spontaneous clearance of chronic hepatitis C virus infection', Journal of Hepatology, vol. 65, pp. 266 - 272, http://dx.doi.org/10.1016/j.jhep.2016.04.030

Weir A; McLeod A; Innes H; Valerio H; Aspinall EJ; Goldberg DJ; Barclay ST; Dillon JF; Fox R; Fraser A; Hayes PC; Kennedy N; Mills PR; Stanley AJ; Aitken C; Gunson R; Templeton K; Hunt A; McIntyre P; Hutchinson SJ, 2016, 'Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs', Drug and Alcohol Dependence, vol. 165, pp. 53 - 60, http://dx.doi.org/10.1016/j.drugalcdep.2016.05.012

Bulteel N; Partha Sarathy P; Forrest E; Innes H; Mills P; Valerio H; Stanley A; Gunson RN; Aitken C; Morris J; Barclay ST, 2015, 'O062 : Factors associated with spontaneous clearance of chronic hepatitis C virus infection: A retrospective case control study', Journal of Hepatology, vol. 62, pp. S222 - S222, http://dx.doi.org/10.1016/s0168-8278(15)30076-3

Hutchinson SJ; Dillon JF; Fox R; McDonald SA; Innes HA; Weir A; McLeod A; Aspinall EJ; Palmateer NE; Taylor A; Munro A; Valerio H; Brown G; Goldberg DJ, 2015, 'Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience', International Journal of Drug Policy, vol. 26, pp. 1041 - 1049, http://dx.doi.org/10.1016/j.drugpo.2015.05.019

Innes HA; Mcdonald SA; Dillon JF; Allen S; Hayes PC; Goldberg D; Mills PR; Barclay ST; Wilks D; Valerio H; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley AJ; Bramley P; Hutchinson SJ, 2015, 'Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes', Hepatology, vol. 62, pp. 355 - 364, http://dx.doi.org/10.1002/hep.27766

Valerio H; Goldberg DJ; Lewsey J; Weir A; Allen S; Aspinall EJ; Barclay ST; Bramley P; Dillon JF; Fox R; Fraser A; Hayes PC; Innes H; Kennedy N; Mills PR; Stanley AJ; Hutchinson SJ, 2015, 'Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection', Drug and Alcohol Dependence, vol. 154, pp. 125 - 131, http://dx.doi.org/10.1016/j.drugalcdep.2015.06.032

Nhean S; Nyborn J; Hinchey D; Valerio H; Kinzel K; Siegel M; Jernigan DH, 2014, 'The frequency of company-sponsored alcohol brand-related sites on facebook™ -2012', Substance Use and Misuse, vol. 49, pp. 779 - 782, http://dx.doi.org/10.3109/10826084.2014.880177

Valerio HM; Hutchinson SJ; Goldberg DJ; Lewsey J; Weir A; Innes H, 2014, 'P1292 EVIDENCE OF CONTINUED INJECTING DRUG USE AFTER ATTAINING SUSTAINED TREATMENT-INDUCED CLEARANCE OF THE HEPATITIS C VIRUS: IMPLICATIONS FOR RE-INFECTION', Journal of Hepatology, vol. 60, pp. S520 - S521, http://dx.doi.org/10.1016/s0168-8278(14)61451-3

Weir A; Innes H; Mcleod A; Valerio H; Goldberg D; Hutchinson S, 2014, 'O91 EVIDENCE OF REINFECTION WITH HEPATITIS C FOLLOWING SUCCESSFUL TREATMENT WITH ANTIVIRAL THERAPY AMONG PEOPLE WHO INJECT DRUGS IN SCOTLAND', Journal of Hepatology, vol. 60, pp. S37 - S37, http://dx.doi.org/10.1016/s0168-8278(14)60093-3

Diloreto JT; Siegel M; Hinchey D; Valerio H; Kinzel K; Lee S; Chen K; Shoaff JR; Kenney J; Jernigan DH; Dejong W, 2012, 'Assessment of the Average Price and Ethanol Content of Alcoholic Beverages by Brand-United States, 2011', Alcoholism: Clinical and Experimental Research, vol. 36, pp. 1288 - 1297, http://dx.doi.org/10.1111/j.1530-0277.2011.01721.x

Alavi M; Valerio H; Law M; Lockart I; Danta M; Grebely J; Amin J; Hajarizadeh B; George J; Dore G, 2022, 'Incidence and risk factors of hepatitis C liver morbidity and mortality in the era of direct-acting antiviral therapies: a population-based linkage study', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 77, pp. S568 - S569, http://dx.doi.org/10.1016/s0168-8278(22)01458-1

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J, 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study', in International Journal of Drug Policy, WILEY, pp. S146 - S147, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Valerio H, 2021, Elimination of hepatitis C virus among people who inject drugs in Australia

Valerio H; Alavi M; Silk D; Treloar C; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Degenhardt L; Dore G; Grebely J, 2019, 'Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage study', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E42 - E42, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30076-3

Hutchinson SJ; Valerio H; Dillon JF; Fox R; Innes H; Weir A; Barclay ST; McDonald SA; Kennedy N; Fraser A; Stanley A; Bramley P; Hayes P; Goldberg DJ, 2018, 'Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis', in Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis, EASL, presented at EASL

Alavi M; Janjua N; Yu A; Grebely J; Aspinall E; Innes H; Valerio H; Hayes P; Krajden M; Amin J; Law M; George J; Goldberg D; Hutchinson S; Dore G, 2016, 'DOES ALCOHOL DEPENDENCY EXPLAIN DIFFERENCES IN RATES OF DECOMPENSATED CIRRHOSIS AMONG PEOPLE WITH A HEPATITIS C NOTIFICATION? AN INTERNATIONAL COMPARISON', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Barcelona, SPAIN, Vol. 64, pp. S462 - S463, presented at EASL International Liver Congress, Barcelona, SPAIN, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)00776-5